| Literature DB >> 30013682 |
Lucky S Mulwa1,2, Rolf Jansen1, Dimas F Praditya3, Kathrin I Mohr1,2, Patrick W Okanya4, Joachim Wink2, Eike Steinmann3,5, Marc Stadler1.
Abstract
Lanyamycin (1/2), a secondary metabolite occurring as two epimers, was isolated from the myxobacterium Sorangium cellulosum, strain Soce 481. The structures of both epimers were elucidated from HRESIMS and 1D and 2D NMR data and the relative configuration of their macrolactone ring was assigned based on NOE and vicinal 1H NMR coupling constants and by calculation of a 3D model. Lanyamycin inhibited HCV infection into mammalian liver cells with an IC50 value of 11.8 µM, and exhibited a moderate cytotoxic activity against the mouse fibroblast cell line L929 and the human nasopharyngeal cell line KB3 with IC50 values of 3.1 and 1.5 μM, respectively, and also suppressed the growth of the Gram-positive bacterium Micrococcus luteus.Entities:
Keywords: HCV; Sorangium cellulosum; antimicrobial; lanyamycin; macrolide
Year: 2018 PMID: 30013682 PMCID: PMC6037015 DOI: 10.3762/bjoc.14.132
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Lanyamycin (1/2), differing at C-26, isolated from Sorangium cellulosum (Soce 481).
NMR data of lanyamycin epimers (1 and 2) in CD3OD at (150/125 MHz).
| pos. | δC | type | δH | H mult. ( | pos. | δC | type | δH | H mult. ( |
| 1 | 166.06 | C | 1 | 166.03 | C | ||||
| 2 | 143.04 | C | 2 | 143.07 | C | ||||
| 3 | 133.63 | CH | 6.53 | br s | 3 | 133.57 | CH | 6.55 | d (0.7) |
| 4 | 132.61 | C | 4 | 132.62 | C | ||||
| 5 | 147.62 | CH | 5.38 | d (9.9) | 5 | 147.55 | CH | 5.39 | br d (10.1) |
| 6 | 39.67 | CH | 2.39 | tq (10.0, 6.6) | 6 | 39.67 | CH | 2.40 | tq (10.0, 6.6) |
| 7 | 77.22 | CH | 3.38 | br d (10.1) | 7 | 77.24 | CH | 3.39 | br d (10.5) |
| 8 | 42.99 | CH | 1.48 | m (9.8, 7.0, 3.1) | 8 | 42.99 | CH | 1.50 | dqd (9.9, 6.8, 3.0) |
| 9a | 38.78 | CH2 | 2.03 | ma | 9a | 38.78 | CH2 | 2.05 | ma |
| 9b | 1.88 | dd (14.5, 6.4) | 9b | 1.89 | br ddd (12.4, 9.9, 2.0) | ||||
| 10 | 138.29 | CH | 6.16 | ddd (15.3, 9.5, 5.7) | 10 | 138.26 | CH | 6.17 | ddd (15.3, 9.8, 5.7) |
| 11 | 132.75 | CH | 6.01 | dd (15.1, 10.4) | 11 | 132.78 | CH | 6.03 | dd (15.3, 10.5) |
| 12 | 139.79 | CH | 6.50 | dd (15.2, 10.6) | 12 | 139.76 | CH | 6.51 | dd (15.2, 10.4) |
| 13 | 128.95 | CH | 5.17 | dd (15.1, 9.3) | 13 | 128.99 | CH | 5.20 | br dd (15.1, 9.5) |
| 14 | 85.75 | CH | 3.76 | t (9.5) | 14 | 85.77 | CH | 3.77 | t (9.5) |
| 15 | 75.84 | CH | 4.81 | ddd (9.8, 6.1, 4.1) | 15 | 75.84 | CH | 4.83 | ddd (10.1, 6.5, 3.7) |
| 16a | 33.21 | CH2 | 2.86 | mb | 16a | 33.20 | CH2 | 2.88 | dddd (15.7, 5.9, 4.0, 0.9)b |
| 16b | 2.80 | mc | 16b | 2.81 | ddd (15.7, 8.8, 6.9)c | ||||
| 17 | 140.25 | CH | 6.85 | br t (7.0) | 17 | 140.16 | CH | 6.85 | ddq (8.6, 6.2, 1.3) |
| 18 | 140.58 | C | 18 | 140.58 | C | ||||
| 19 | 202.54 | C | 19 | 202.53 | C | ||||
| 20a | 43.47 | CH2 | 2.98 | dd (15.5, 2.8) | 20a | 43.35 | CH2 | 2.98 | dd (15.5, 3.0) |
| 20b | 2.77 | dd (15.6, 9.3)c | 20b | 2.78 | dd (15.7, 9.3)c | ||||
| 21 | 72.40 | CH | 4.24 | ddd (9.3, 8.0, 2.7) | 21 | 72.10 | CH | 4.25 | ddd (9.2, 8.0, 3.0) |
| 22 | 51.55 | CH | 3.07 | dq (8.0, 6.9) | 22 | 51.98 | CH | 3.06 | dq (7.8, 7.0) |
| 23 | 217.46 | C=O | 23 | 217.63 | C | ||||
| 24 | 51.00 | CH | 2.89 | qd (7.0, 5.5)b | 24 | 50.73 | CH | 2.91 | qd (6.9, 5.8)b |
| 25 | 74.32 | CH | 3.89 | t (5.5) | 25 | 74.52 | CH | 3.85 | t (5.5) |
| 26 | 75.08 | CH | 5.19 | br d (5.8) | 26 | 75.03 | CH | 5.22 | d (5.2) |
| 27 | 171.87 | C=O | 27 | 171.66 | C | ||||
| 28 | 58.25 | CH | 4.29 | dd (7.6, 6.6) | 28 | 58.29 | CH | 4.34 | dd (7.7, 6.7) |
| 29 | 198.10 | C=O | 29 | 198.19 | C | ||||
| 30 | 138.12 | C | 30 | 138.15 | C | ||||
| 33 | 134.77 | CH | 7.60 | tt (7.4, 1.2) | 33 | 134.81 | CH | 7.63 | tt (7.3, 1.3) |
| 34, 32 | 130.10 | 2 CH | 7.50 | br t (7.8) | 32, 34 | 130.06 | CH | 7.53 | td (7.5, 1.6) |
| 35, 31 | 129.55 | 2 CH | 7.99 | br d (7.5) | 31, 35 | 129.76 | CH | 8.06 | dd (8.4, 1.3) |
| 36 | 60.79 | OCH3 | 3.59 | s | 36 | 60.77 | CH3 | 3.61 | s |
| 37 | 14.56 | CH3 | 1.91 | s | 37 | 14.57 | CH3 | 1.92 | d (1.1) |
| 38 | 17.05 | CH3 | 1.01 | br d (6.6) | 38 | 17.06 | CH3 | 1.03 | br d (6.7) |
| 39 | 15.57 | CH3 | 0.89 | d (7.0) | 39 | 15.57 | CH3 | 0.90 | d (7.1) |
| 40 | 56.65 | OCH3 | 3.27 | s | 40 | 56.67 | CH3 | 3.29 | s |
| 41 | 11.74 | CH3 | 1.79 | s | 41 | 11.74 | CH3 | 1.81 | br s |
| 42 | 13.84 | CH3 | 1.05 | d (6.9) | 42 | 13.71 | CH3 | 1.06 | d (7.1) |
| 43 | 10.51 | CH3 | 0.92 | d (7.0) | 43 | 11.28 | CH3 | 1.07 | d (6.9) |
| 44a | 24.28 | CH2 | 2.01 | mb,d | 44a | 24.62 | CH2 | 2.03 | ma |
| 44b | 1.95 | md | 44b | 1.97 | m | ||||
| 45 | 12.55 | CH3 | 1.03 | t (7.5) | 45 | 12.57 | CH3 | 1.02 | t (7.2) |
a, b, c, dOverlaping 1H signals.
Figure 2Structure fragments of lanyamycin (1/2) from 1H,1H-COSY spectrum (bold bonds) and selected 1H,13C-HMBC NMR correlations (arrows).
Figure 3Structure of bafilomycin A1.
Figure 43D Model of the macrolactone ring of lanyamycin (1/2) and selected ROESY correlations. Green arrows upper side NOEs, blue arrows under side NOEs.
Atom distances in the 3D model for selected ROESY correlations observed in lanyamycin (1/2).
| atom 1/atom 2 | distance [Å] | atom 1/atom 2 | distance [Å] |
| 3/5 | 2.15 | 8/9b | 2.51 |
| 5/7 | 2.42 | 8/11 | 2.96 |
| 5/8 | 2.94 | 9a/10 | 2.47 |
| 5/10 | 2.68 | 9a/39 | 2.69 |
| 6/8 | 2.58 | 9b/11 | 2.44 |
| 6/37 | 2.09 | 9b/39 | 2.47 |
| 6/39 | 2.77 | 10/12 | 2.39 |
| 7/7OH | 2.15 | 11/13 | 2.42 |
| 7/9a | 2.61 | 12/14 | 2.37 |
| 7/10 | 2.39 | 13/15 | 2.69 |
| 7/38 | 2.61 | 13/40 | 2.92 |
| 7-OH/9a | 2.82 | 14/40 | 2.36 |
| 7-OH/38 | 3.34 | ||
| 7-OH/39 | 2.32 | ||
Antimicrobial activity of lanyamycin (1/2).
| test strains | MIC [µg/mL] |
| fungi | |
| 4.2 | |
| 4.2 | |
| 4.2 | |
| Gram-positive bacteria | |
| – | |
| 1.7 | |
| – | |
| Gram-negative bacteria | |
| – | |
| – | |
| – | |
aNystatin, btetracycline, campicillin, dgentamycin.
Cytotoxicity test results of lanyamycin (1/2).
| cell line | IC50 [µM] |
| mouse fibroblasts (L929)a | 3.1 |
| human nasopharyngeal cells (KB3.1)a | 1.5 |
| human colon carcinoma cells (HCT-116)a | 22 |
| human glioblastoma (U87MG)a | 29 |
acontrol: epothilone B.
Figure 5HCV assay: NC = negative control, EGCG = positive control, Cpd1 = lanyamycin (1/2).